Wenxiu Zhao

3.2k total citations
67 papers, 2.4k citations indexed

About

Wenxiu Zhao is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Wenxiu Zhao has authored 67 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 16 papers in Immunology and 13 papers in Cancer Research. Recurrent topics in Wenxiu Zhao's work include RNA modifications and cancer (9 papers), Immune cells in cancer (8 papers) and Cancer-related molecular mechanisms research (6 papers). Wenxiu Zhao is often cited by papers focused on RNA modifications and cancer (9 papers), Immune cells in cancer (8 papers) and Cancer-related molecular mechanisms research (6 papers). Wenxiu Zhao collaborates with scholars based in China, United States and United Kingdom. Wenxiu Zhao's co-authors include Zhenyu Yin, Xun Zhang, Yvonne Li, Xiaomin Wang, Xiaomin Wang, Chengrong Xie, Qiao Wu, Lan Ma, Yaping Xu and Hang‐zi Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Wenxiu Zhao

67 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenxiu Zhao China 28 1.4k 596 577 462 242 67 2.4k
Juan‐José Ventura United States 22 1.8k 1.3× 521 0.9× 650 1.1× 472 1.0× 215 0.9× 34 2.6k
Qiang Du United States 22 741 0.5× 452 0.8× 384 0.7× 397 0.9× 207 0.9× 40 1.5k
Wenchao Liu China 27 1.3k 0.9× 566 0.9× 451 0.8× 327 0.7× 121 0.5× 77 2.1k
Beifang Ning China 23 1.4k 1.0× 929 1.6× 509 0.9× 223 0.5× 359 1.5× 36 2.2k
Tongsen Zheng China 30 1.8k 1.3× 1.1k 1.8× 876 1.5× 688 1.5× 220 0.9× 63 3.2k
Xiaoli Wu China 30 1.8k 1.3× 741 1.2× 438 0.8× 181 0.4× 272 1.1× 82 2.8k
Hisakazu Iwama Japan 26 1.1k 0.8× 547 0.9× 421 0.7× 251 0.5× 233 1.0× 101 1.9k
Ke Pan China 24 958 0.7× 291 0.5× 637 1.1× 561 1.2× 98 0.4× 60 1.8k
Jian Wu China 21 956 0.7× 255 0.4× 474 0.8× 309 0.7× 393 1.6× 91 1.7k
Christèle Desbois‐Mouthon France 27 1.6k 1.2× 538 0.9× 689 1.2× 214 0.5× 371 1.5× 64 2.8k

Countries citing papers authored by Wenxiu Zhao

Since Specialization
Citations

This map shows the geographic impact of Wenxiu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxiu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxiu Zhao more than expected).

Fields of papers citing papers by Wenxiu Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxiu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxiu Zhao. The network helps show where Wenxiu Zhao may publish in the future.

Co-authorship network of co-authors of Wenxiu Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxiu Zhao. A scholar is included among the top collaborators of Wenxiu Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxiu Zhao. Wenxiu Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Tingting, Xianyong Zhao, Thomas P. Loch, et al.. (2025). RNA virus diversity highlights the potential biosecurity threat posed by Antarctic krill. Marine Life Science & Technology. 7(1). 96–109. 1 indexed citations
2.
Zhang, Cheng, Yulong Luo, Z. Y. Deng, et al.. (2025). Recent advances in cold plasma technology for enhancing the safety and quality of meat and meat products: A comprehensive review. Food Research International. 202. 115701–115701. 7 indexed citations
3.
Fang, Ting, et al.. (2023). Lenvatinib inhibited HCC cell migration and invasion through regulating the transcription and ubiquitination of UHRF1 and DNMT1. Biochemical Pharmacology. 210. 115489–115489. 14 indexed citations
4.
Cao, Jiahao, et al.. (2023). CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway. Journal of Translational Medicine. 21(1). 539–539. 9 indexed citations
5.
Zhao, Wenxiu, Xiaobin Jiang, Jun Ma, et al.. (2022). High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors. Frontiers in Oncology. 12. 875122–875122. 6 indexed citations
6.
Xu, Jiahong, Wenxiu Zhao, Qing Zeng, et al.. (2021). Third-generation sequencing and metabolome analysis reveal candidate genes and metabolites with altered levels in albino jackfruit seedlings. BMC Genomics. 22(1). 543–543. 15 indexed citations
7.
Lu, Yuyan, Heping Zhu, Wenxiu Zhao, et al.. (2021). The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic Target. SHILAP Revista de lepidopterología. Volume 8. 451–465. 66 indexed citations
8.
Zhao, Wenxiu, Lingxiang Jiang, Ting Fang, et al.. (2021). β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation. Frontiers in Oncology. 11. 747282–747282. 21 indexed citations
9.
Guan, Yun‐Feng, Qiaoling Huang, Yuan-li Ai, et al.. (2020). Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis. Oncogene. 39(11). 2408–2423. 64 indexed citations
10.
Feng, Min, Fei Fang, Ting Fang, et al.. (2020). Sox13 promotes hepatocellular carcinoma metastasis by transcriptionally activating Twist1. Laboratory Investigation. 100(11). 1400–1410. 24 indexed citations
11.
12.
Lv, Jie, Sheng Zhang, Huita Wu, et al.. (2019). Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2. Cancer Letters. 469. 22–34. 83 indexed citations
13.
Zhao, Yue, You Song, Yaqi Yu, et al.. (2019). Decreased nuclear expression of FTO in human primary hepatocellular carcinoma is associated with poor prognosis.. PubMed. 12(9). 3376–3383. 17 indexed citations
14.
Liang, Shaohua, Pengtao Li, Chengrong Xie, et al.. (2018). Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7. Biochemical and Biophysical Research Communications. 502(1). 30–42. 20 indexed citations
15.
Zhao, Wenxiu, et al.. (2017). High expression of Rap2A is associated with poor prognosis of patients with hepatocellular carcinoma.. PubMed. 10(9). 9607–9613. 11 indexed citations
16.
Lin, Shao Jian, Ze Wu, Yu Guo, et al.. (2017). Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death. Autophagy. 13(8). 1404–1419. 81 indexed citations
17.
Xu, Yaping, Wenxiu Zhao, Jianfeng Xu, et al.. (2016). Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2. Oncotarget. 7(8). 8866–8878. 70 indexed citations
18.
Xie, Chengrong, Hongguang Sun, Fuqiang Wang, et al.. (2015). Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes. Molecular Medicine Reports. 12(3). 4250–4258. 29 indexed citations
19.
Cai, Wangyu, Qicong Luo, Qiu-Wan Wu, et al.. (2013). Wnt/β-catenin pathway represses let-7 microRNAs expression via transactivation of Lin28 to augment breast cancer stem cell expansion. Journal of Cell Science. 126(Pt 13). 2877–89. 111 indexed citations
20.
Zhao, Wenxiu, Guangli Ren, Lei Zhang, et al.. (2012). Efficacy of Mesenchymal Stem Cells Derived from Human Adipose Tissue in Inhibition of Hepatocellular Carcinoma Cells In Vitro. Cancer Biotherapy and Radiopharmaceuticals. 27(9). 606–613. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan‐José Ventura Breakdown of academic impact, for papers by Qiang Du Breakdown of academic impact, for papers by Wenchao Liu Breakdown of academic impact, for papers by Beifang Ning Breakdown of academic impact, for papers by Tongsen Zheng Breakdown of academic impact, for papers by Xiaoli Wu Breakdown of academic impact, for papers by Hisakazu Iwama Breakdown of academic impact, for papers by Ke Pan Breakdown of academic impact, for papers by Jian Wu Breakdown of academic impact, for papers by Christèle Desbois‐Mouthon
Rankless by CCL
2026